Coronavirus disease 2019 (COVID-19) has resulted in a global pandemic, challenging both the medical and scientific community for the development of novel vaccines and a greater …
S Chatterjee, LV Nalla, M Sharma… - ACS Pharmacology & …, 2023 - ACS Publications
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …
Aims To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID …
S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
Introduction Patients with immunodeficiency are usually more prone to worse outcomes of infectious diseases. However, there are some disagreements in the context of COVID-19, for …
Background COVID-19 causes fatal cardiac damages. Despite many overwhelming meta- analysis related to cardiac complications following COVID-19 disease, no umbrella meta …
VA Arumugam, S Thangavelu, Z Fathah… - J Pure Appl …, 2020 - academia.edu
Newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) pandemic has now spread across the globe in past …
Abstract Background The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV- 2) emerged initially in China in December 2019 causing the COVID-19 disease, which …
S Garcia‐Zamora, S Lee, S Haseeb… - Pacing and Clinical …, 2021 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) primarily causes lung infection, but recent studies have shown that cardiac involvement is associated with a worse …